Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 121

1.

White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder.

Köhler O, Sylvia LG, Bowden CL, Calabrese JR, Thase M, Shelton RC, McInnis M, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Deckersbach T, Ostacher MJ, Iosifescu DV, McElroy S, Nierenberg AA.

Aust N Z J Psychiatry. 2016 Apr 28. pii: 0004867416644508. [Epub ahead of print]

PMID:
27126391
2.

Ketamine for treatment-resistant depression: recent developments and clinical applications.

Schwartz J, Murrough JW, Iosifescu DV.

Evid Based Ment Health. 2016 Apr 6. pii: ebmental-2016-102355. doi: 10.1136/eb-2016-102355. [Epub ahead of print]

PMID:
27053196
3.

Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis.

Cassano P, Petrie SR, Hamblin MR, Henderson TA, Iosifescu DV.

Neurophotonics. 2016 Jul;3(3):031404. doi: 10.1117/1.NPh.3.3.031404. Epub 2016 Mar 4. Review.

PMID:
26989758
4.

A clinical measure of suicidal ideation, suicidal behavior, and associated symptoms in bipolar disorder: Psychometric properties of the Concise Health Risk Tracking Self-Report (CHRT-SR).

Ostacher MJ, Nierenberg AA, Rabideau D, Reilly-Harrington NA, Sylvia LG, Gold AK, Shesler LW, Ketter TA, Bowden CL, Calabrese JR, Friedman ES, Iosifescu DV, Thase ME, Leon AC, Trivedi MH.

J Psychiatr Res. 2015 Dec;71:126-33. doi: 10.1016/j.jpsychires.2015.10.004. Epub 2015 Oct 9.

PMID:
26476489
5.

Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study.

Cassano P, Cusin C, Mischoulon D, Hamblin MR, De Taboada L, Pisoni A, Chang T, Yeung A, Ionescu DF, Petrie SR, Nierenberg AA, Fava M, Iosifescu DV.

Psychiatry J. 2015;2015:352979. doi: 10.1155/2015/352979. Epub 2015 Aug 19.

6.

Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial.

Murrough JW, Soleimani L, DeWilde KE, Collins KA, Lapidus KA, Iacoviello BM, Lener M, Kautz M, Kim J, Stern JB, Price RB, Perez AM, Brallier JW, Rodriguez GJ, Goodman WK, Iosifescu DV, Charney DS.

Psychol Med. 2015 Dec;45(16):3571-80. doi: 10.1017/S0033291715001506. Epub 2015 Aug 12.

PMID:
26266877
7.

Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression.

Leuchter AF, Cook IA, Feifel D, Goethe JW, Husain M, Carpenter LL, Thase ME, Krystal AD, Philip NS, Bhati MT, Burke WJ, Howland RH, Sheline YI, Aaronson ST, Iosifescu DV, O'Reardon JP, Gilmer WS, Jain R, Burgoyne KS, Phillips B, Manberg PJ, Massaro J, Hunter AM, Lisanby SH, George MS.

Brain Stimul. 2015 Jul-Aug;8(4):787-94. doi: 10.1016/j.brs.2015.05.005. Epub 2015 May 22.

PMID:
26143022
8.

Maintaining the initial clinical response after ketamine in bipolar and unipolar depression: an important next-step challenge.

Iosifescu DV.

J Clin Psychiatry. 2015 Jun;76(6):738-40. doi: 10.4088/JCP.15com09904. No abstract available.

9.

Genetic Differences in the Immediate Transcriptome Response to Stress Predict Risk-Related Brain Function and Psychiatric Disorders.

Arloth J, Bogdan R, Weber P, Frishman G, Menke A, Wagner KV, Balsevich G, Schmidt MV, Karbalai N, Czamara D, Altmann A, Trümbach D, Wurst W, Mehta D, Uhr M, Klengel T, Erhardt A, Carey CE, Conley ED; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium (PGC), Ruepp A, Müller-Myhsok B, Hariri AR, Binder EB; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium PGC.

Neuron. 2015 Jun 3;86(5):1189-202. doi: 10.1016/j.neuron.2015.05.034.

10.

The association between lower educational attainment and depression owing to shared genetic effects? Results in ~25,000 subjects.

Peyrot WJ, Lee SH, Milaneschi Y, Abdellaoui A, Byrne EM, Esko T, de Geus EJ, Hemani G, Hottenga JJ, Kloiber S, Levinson DF, Lucae S; Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium (Corporate Collaborator), Martin NG, Medland SE, Metspalu A, Milani L, Noethen MM, Potash JB, Rietschel M, Rietveld CA, Ripke S, Shi J; Social Science Genetic Association Consortium Corporate Collaborator, Willemsen G, Zhu Z, Boomsma DI, Wray NR, Penninx BW; Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium Corporate Collaborator; Social Science Genetic Association Consortium Corporate Collaborator.

Mol Psychiatry. 2015 Jun;20(6):735-43. doi: 10.1038/mp.2015.50. Epub 2015 Apr 28.

PMID:
25917368
11.

In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature.

Lener MS, Iosifescu DV.

Ann N Y Acad Sci. 2015 May;1344:50-65. doi: 10.1111/nyas.12759. Epub 2015 Apr 8. Review.

PMID:
25854817
12.

Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder.

Murrough JW, Collins KA, Fields J, DeWilde KE, Phillips ML, Mathew SJ, Wong E, Tang CY, Charney DS, Iosifescu DV.

Transl Psychiatry. 2015 Feb 17;5:e509. doi: 10.1038/tp.2015.10.

13.

The association of post-stroke anhedonia with salivary cortisol levels and stroke lesion in hippocampal/parahippocampal region.

Terroni L, Amaro E Jr, Iosifescu DV, Mattos P, Yamamoto FI, Tinone G, Conforto AB, Sobreiro MF, Guajardo VD, De Lucia MC, Moreira AC, Scaff M, Leite CC, Fraguas R.

Neuropsychiatr Dis Treat. 2015 Feb 3;11:233-42. doi: 10.2147/NDT.S73722. eCollection 2015.

14.

The promise of ketamine for treatment-resistant depression: current evidence and future directions.

DeWilde KE, Levitch CF, Murrough JW, Mathew SJ, Iosifescu DV.

Ann N Y Acad Sci. 2015 May;1345:47-58. doi: 10.1111/nyas.12646. Epub 2015 Feb 3. Review.

PMID:
25649308
15.

Seasonality shows evidence for polygenic architecture and genetic correlation with schizophrenia and bipolar disorder.

Byrne EM; Psychiatric Genetics Consortium Major Depressive Disorder Working Group, Raheja UK, Stephens SH, Heath AC, Madden PA, Vaswani D, Nijjar GV, Ryan KA, Youssufi H, Gehrman PR, Shuldiner AR, Martin NG, Montgomery GW, Wray NR, Nelson EC, Mitchell BD, Postolache TT.

J Clin Psychiatry. 2015 Feb;76(2):128-34. doi: 10.4088/JCP.14m08981.

16.

The influence of depressive symptoms on quality of life after stroke: a prospective study.

Guajardo VD, Terroni L, Sobreiro Mde F, Zerbini MI, Tinone G, Scaff M, Iosifescu DV, de Lucia MC, Fráguas R.

J Stroke Cerebrovasc Dis. 2015 Jan;24(1):201-9. doi: 10.1016/j.jstrokecerebrovasdis.2014.08.020. Epub 2014 Nov 12.

PMID:
25440338
17.

Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.

Murrough JW, Burdick KE, Levitch CF, Perez AM, Brallier JW, Chang LC, Foulkes A, Charney DS, Mathew SJ, Iosifescu DV.

Neuropsychopharmacology. 2015 Mar 13;40(5):1084-90. doi: 10.1038/npp.2014.298.

18.

Ketamine safety and tolerability in clinical trials for treatment-resistant depression.

Wan LB, Levitch CF, Perez AM, Brallier JW, Iosifescu DV, Chang LC, Foulkes A, Mathew SJ, Charney DS, Murrough JW.

J Clin Psychiatry. 2015 Mar;76(3):247-52. doi: 10.4088/JCP.13m08852.

PMID:
25271445
19.

The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorder.

Sylvia LG, Rabideau DJ, Nierenberg AA, Bowden CL, Friedman ES, Iosifescu DV, Thase ME, Ketter T, Greiter EA, Calabrese JR, Leon AC, Ostacher MJ, Reilly-Harrington N.

J Affect Disord. 2014 Dec;169:144-8. doi: 10.1016/j.jad.2014.08.019. Epub 2014 Aug 20.

20.

Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depression.

Treadway MT, Waskom ML, Dillon DG, Holmes AJ, Park MT, Chakravarty MM, Dutra SJ, Polli FE, Iosifescu DV, Fava M, Gabrieli JD, Pizzagalli DA.

Biol Psychiatry. 2015 Feb 1;77(3):285-94. doi: 10.1016/j.biopsych.2014.06.018. Epub 2014 Jul 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk